United States · FDA National Drug Code directory
losartan potassium and hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-671_2d778122-9382-4e15-a927-d652112b3606
- Product NDC
- 71610-671
- Form
- TABLET, FILM COATED
- Composition / generic term
- losartan potassium and hydrochlorothiazide
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170721
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROCHLOROTHIAZIDE — 25 mg/1
- LOSARTAN POTASSIUM — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-671-30) · 71610-671-30
- 45 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-671-45) · 71610-671-45
- 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-671-53) · 71610-671-53
- 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-671-60) · 71610-671-60
- 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-671-70) · 71610-671-70
- 180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-671-80) · 71610-671-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →